← Eichor
Study identifier: NCT06287112 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prevention of Acute Cholecystitis With ETGBD

Condition: Biliary Obstruction · Acute Cholecystitis  ·  Sponsor: Seoul National University Hospital

PhaseNA
Planned participants35
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn about Efficacy of the ETGBD parallel insertion with fully covered self-expandable metal stent for preventing acute cholecystitis in patients with low cystic duct insertion. In this study, we hypothesized that endoscopic transpapillary gallbladder drainage (ETGBD) with parallel insertion of a fully covered self-expanding metal stent(FCSEMS) through an endoscopic biliary drainage tunnel is superior in preventing complications such as cholecystitis when the gallbladder ducts confluence within the distal third of the common bile duct. And we aimed to confirm its efficacy by comparing the frequency, severity, and rate of invasive additional procedures due to cholecystitis complications to provide evidence of clinical utility.

This description comes directly from the study's public registry record.

Talk to the study team

Myeong Hwan Lee, MD.  ·  +82-10-7733-6494  ·  dlaudghks01@snu.ac.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National University HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06287112